Animal models have greatly improved the understanding of researchers related to the pathophysiology of various diseases like rheumatoid arthritis, systemic lupus erythematosus synovial hyperplasia, mononuclear cell infiltration, cartilage and bone erosions and many more have provided valuable insights for testing potential therapeutic treatment.
Top impacting factors: Market Scenario Analysis
Animal model have been extensively used in experimental research to enhance human understandings and find the solutions to complex biological and biomedical constraints and has been highly preferred as means of experiment by scientists and researchers. For cosmetic research and for testing different therapeutic treatments, animal models are commonly used. New drugs are tested first on animals for safety and efficacy and checking the side effects before they are examined for human use. Mere 5% of the drugs derived from animal models are suitable for humans which highlights the scope that exists with abundant opportunities for research and investment in the field.
However, use of animal models being an expensive and time-consuming process, the strict regulations and guidelines while using animal models for research and the growing use of animals such as monkeys and dogs has raised concern among various animal welfare organizations and NGOs which has resulted in the research organizations to find new ways to reduce the number of animals in research. These factors have been limiting the growth of the animal model market.
Use of animal models for vaccine development
The development of human vaccines depends extensively on animal models by a large. Several regulatory authorities have a mandate for novel vaccine candidates to go through preclinical where testing is done primarily on animal models before being eligible for experimentation on human subjects. A noteworthy change regarding reduction and replacement of animals as models has been witnessed in the recent years with the advancements in computational biology and bioinformatics methodologies for developing novel vaccine candidates.
Key benefits of the report:
- This study presents the analytical depiction of the global clinical workflow solutions stem industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global animal model market share.
- The current market is quantitatively analyzed from 2020 to 2027 to highlight the global clinical workflow solutions market growth scenario.
Companies covered:
Charles River Laboratories International, Horizon Discovery, The Jackson Laboratory, Taconic Biosciences, GenOway S.A., Eurofins Scientific, Crown Bioscience Inc., Envigo, Transposagen Biopharmaceuticals Inc.
0 Comments